Metraipolis › archive › dc_f4e761c6ec16
Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response — Europe PMC PMID:42328454
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42328454
- DOI
- 10.7150/ijbs.130955
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T18:33:09.616Z
- SHA-256 of the archived text
8abbdd4874b876bf7b0f26ce2335e62322f4a446d4bd3371477773ba0f32a675- Stable URL of this page
https://metraipolis.com/documento/dc_f4e761c6ec16
How to cite
Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response — Europe PMC PMID:42328454 — Europe PMC (en), https://europepmc.org/article/MED/42328454 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f4e761c6ec16 (Metraipolis archive dc_f4e761c6ec16, sha256 8abbdd4874b876bf7b0f26ce2335e62322f4a446d4bd3371477773ba0f32a675)
BibTeX
@misc{dcf4e761c6ec16,
title = {Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response — Europe PMC PMID:42328454},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42328454},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f4e761c6ec16; sha256 8abbdd4874b876bf7b0f26ce2335e62322f4a446d4bd3371477773ba0f32a675},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42328454. Agents can read the archived copy with the MCP tool read_document.